Marvell
Marvell’s $115bn all-stock deal for Lumentum sent both shares sharply lower. Terms, analyst views and what to watch next.
Marvell’s $115bn all-stock deal for Lumentum sent both shares sharply lower. Terms, analyst views and what to watch next.